Cooper Companies (COO) Non-Current Deffered Revenue (2021 - 2026)
Cooper Companies (COO) posted quarterly Non-Current Deffered Revenue of $208.8 million for Q2 2026, up 6.31% year-over-year from $196.4 million in Q2 2025, and up 1.16% quarter-over-quarter from $206.4 million in Q1 2026.
Cooper Companies (COO) Non-Current Deffered Revenue (2021 - 2026) Analysis & Trends
Cooper Companies' Non-Current Deffered Revenue history runs 6 years deep, the most recent figure standing at $208.8 million for Q2 2026.
- In Q2 2026, Non-Current Deffered Revenue rose 6.31% year-over-year to $208.8 million; the TTM figure through Apr 2026 stood at $208.8 million (up 6.31% YoY), while the FY2025 annual figure was $201.8 million, up 4.4% from the prior year.
- Non-Current Deffered Revenue for Q2 2026 stood at $208.8 million, up from $206.4 million in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $208.8 million in Q2 2026, with the low at $182.6 million in Q2 2023.
- The 5-year median for Non-Current Deffered Revenue is $193.4 million (2025), against an average of $194.1 million.
- The sharpest annual moves came in 2022 and 2023: Non-Current Deffered Revenue surged 198200.0% in 2022, then decreased 7.11% in 2023.
- Cooper Companies' Non-Current Deffered Revenue stood at $198.3 million in 2022, then fell by 7.11% to $184.2 million in 2023, then climbed by 4.94% to $193.3 million in 2024, then gained by 4.4% to $201.8 million in 2025, then advanced by 3.47% to $208.8 million in 2026.
- Business Quant data shows COO's Non-Current Deffered Revenue at $208.8 million in Q2 2026, $206.4 million in Q1 2026, and $201.8 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 170.95 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 13.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 208.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 208.80 Mn |
| Jan 31, 2026 | 206.40 Mn |
| Oct 31, 2025 | 201.80 Mn |
| Jul 31, 2025 | 199.40 Mn |
| Apr 30, 2025 | 196.40 Mn |
| Jan 31, 2025 | 193.40 Mn |
| Oct 31, 2024 | 193.30 Mn |
| Jul 31, 2024 | 190.80 Mn |
| Apr 30, 2024 | 188.60 Mn |
| Jan 31, 2024 | 186.30 Mn |
| Oct 31, 2023 | 184.20 Mn |
| Jul 31, 2023 | 185.50 Mn |
| Apr 30, 2023 | 182.60 Mn |
| Jan 31, 2023 | 195.10 Mn |
| Oct 31, 2022 | 198.30 Mn |
| Oct 31, 2021 | 100,000.00 |